These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 35123819)

  • 21. The Association of Tissue Change and Treatment Success During High-intensity Focused Ultrasound Focal Therapy for Prostate Cancer.
    Khandwala YS; Soerensen SJC; Morisetty S; Ghanouni P; Fan RE; Vesal S; Rusu M; Sonn GA
    Eur Urol Focus; 2023 Jul; 9(4):584-591. PubMed ID: 36372735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Focal High Intensity Focused Ultrasound of Unilateral Localized Prostate Cancer: A Prospective Multicentric Hemiablation Study of 111 Patients.
    Rischmann P; Gelet A; Riche B; Villers A; Pasticier G; Bondil P; Jung JL; Bugel H; Petit J; Toledano H; Mallick S; Rouvière O; Rabilloud M; Tonoli-Catez H; Crouzet S
    Eur Urol; 2017 Feb; 71(2):267-273. PubMed ID: 27720531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-intensity focused ultrasound for the treatment of prostate cancer: A prospective trial with long-term follow-up.
    Mearini L; D'Urso L; Collura D; Nunzi E; Muto G; Porena M
    Scand J Urol; 2015; 49(4):267-74. PubMed ID: 25485722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evolution and outcomes of 3 MHz high intensity focused ultrasound therapy for localized prostate cancer during 15 years.
    Thüroff S; Chaussy C
    J Urol; 2013 Aug; 190(2):702-10. PubMed ID: 23415962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-center, prospective phase 2 trial of high-intensity focused ultrasound (HIFU) in patients with unilateral localized prostate cancer: good functional results but oncologically not as safe as expected.
    Duwe G; Boehm K; Haack M; Sparwasser P; Brandt MP; Mager R; Tsaur I; Haferkamp A; Höfner T
    World J Urol; 2023 May; 41(5):1293-1299. PubMed ID: 36920492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Focal high-intensity focused ultrasound therapy for localized prostate cancer: An interim analysis of the multinational FASST study.
    Ladjevardi S; Ebner A; Femic A; Huebner NA; Shariat SF; Kraler S; Kubik-Huch RA; Ahlman RC; Häggman M; Hefermehl LJ
    Eur J Clin Invest; 2024 Jun; 54(6):e14192. PubMed ID: 38445798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Focal salvage therapy for localized prostate cancer recurrence after external beam radiotherapy: a pilot study.
    Ahmed HU; Cathcart P; McCartan N; Kirkham A; Allen C; Freeman A; Emberton M
    Cancer; 2012 Sep; 118(17):4148-55. PubMed ID: 22907704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study.
    Asimakopoulos AD; Miano R; Virgili G; Vespasiani G; Finazzi Agrò E
    Urol Oncol; 2012 Sep; 30(5):577-83. PubMed ID: 21292508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term outcomes of whole gland high-intensity focused ultrasound for localized prostate cancer.
    Lo Verde K; Toledano H; Campagna J; Rossi D; Bastide C; Baboudjian M
    Int Urol Nephrol; 2022 Jun; 54(6):1233-1238. PubMed ID: 35397077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results of high intensity focused ultrasound treatment of prostate cancer: early Canadian experience at a single center.
    Elterman DS; Barkin J; Radomski SB; Fleshner NE; Liu B; Bensimon K; Arora S; Robinette M; Finelli A
    Can J Urol; 2011 Dec; 18(6):6037-42. PubMed ID: 22166332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salvage high-intensity focused ultrasound (HIFU) for locally recurrent prostate cancer after failed radiation therapy: Multi-institutional analysis of 418 patients.
    Crouzet S; Blana A; Murat FJ; Pasticier G; Brown SCW; Conti GN; Ganzer R; Chapet O; Gelet A; Chaussy CG; Robertson CN; Thuroff S; Ward JF
    BJU Int; 2017 Jun; 119(6):896-904. PubMed ID: 28063191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIFU focal therapy for prostate cancer using intraoperatory contrast enhanced ultrasound.
    Claros OR; Tourinho-Barbosa RR; Carneiro A; Collura-Merlier S; Macek P; Lanz C; Cathala N; Prapotnich D; Mombet A; Sanchez-Salas R; Cathelineau X
    Arch Esp Urol; 2019 Oct; 72(8):825-830. PubMed ID: 31579041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salvage High-Intensity Focused Ultrasound for Local Recurrence in the Prostatic Bed after Prostatectomy and Adjuvant or Salvage Radiotherapy: Preliminary Results.
    Khedime S; Gelet A; Rouvière O; Lafon C; Badet L; Crouzet S; Hostiou T
    J Urol; 2021 Aug; 206(2):325-337. PubMed ID: 33835863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathological, Oncologic and Functional Outcomes of a Prospective Registry of Salvage High Intensity Focused Ultrasound Ablation for Radiorecurrent Prostate Cancer.
    Siddiqui KM; Billia M; Arifin A; Li F; Violette P; Chin JL
    J Urol; 2017 Jan; 197(1):97-102. PubMed ID: 27422297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostate Specific Antigen Criteria to Diagnose Failure of Cancer Control following Focal Therapy of Nonmetastatic Prostate Cancer Using High Intensity Focused Ultrasound.
    Huber PM; Afzal N; Arya M; Boxler S; Dudderidge T; Emberton M; Guillaumier S; Hindley RG; Hosking-Jervis F; Leemann L; Lewi H; McCartan N; Moore CM; Nigam R; Odgen C; Persad R; Thalmann GN; Virdi J; Winkler M; Ahmed HU
    J Urol; 2020 Apr; 203(4):734-742. PubMed ID: 31928408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective clinical trial of HIFU hemiablation for clinically localized prostate cancer.
    van Velthoven R; Aoun F; Marcelis Q; Albisinni S; Zanaty M; Lemort M; Peltier A; Limani K
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):79-83. PubMed ID: 26597660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemi salvage high-intensity focused ultrasound (HIFU) in unilateral radiorecurrent prostate cancer: a prospective two-centre study.
    Baco E; Gelet A; Crouzet S; Rud E; Rouvière O; Tonoli-Catez H; Berge V; Chapelon JY; Eggesbø HB
    BJU Int; 2014 Oct; 114(4):532-40. PubMed ID: 24930692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medium-term oncological outcomes in a large cohort of men treated with either focal or hemi-ablation using high-intensity focused ultrasonography for primary localized prostate cancer.
    Stabile A; Orczyk C; Hosking-Jervis F; Giganti F; Arya M; Hindley RG; Dickinson L; Allen C; Punwani S; Jameson C; Freeman A; McCartan N; Montorsi F; Briganti A; Ahmed HU; Emberton M; Moore CM
    BJU Int; 2019 Sep; 124(3):431-440. PubMed ID: 30753756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-intensity focused ultrasound (HIFU) for definitive treatment of prostate cancer.
    Cordeiro ER; Cathelineau X; Thüroff S; Marberger M; Crouzet S; de la Rosette JJ
    BJU Int; 2012 Nov; 110(9):1228-42. PubMed ID: 22672199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of oncological outcomes of whole-gland therapy with high-intensity focused ultrasound for localized prostate cancer in clinical and technical aspects: a retrospective consecutive case-series analysis with a median 5-year follow-up.
    Shoji S; Uchida T; Hanada I; Takahashi K; Yuzuriha S; Kano T; Ogawa T; Umemoto T; Kawakami M; Nitta M; Hashida K; Hasegawa M; Hasebe T; Miyajima A
    Int J Hyperthermia; 2021; 38(1):1205-1216. PubMed ID: 34375163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.